Fig. 3
From: In vitro drug testing using patient-derived ovarian cancer organoids
Drug testing and personalized therapy of ovarian cancer in OV-PDOs. Dose–response curves of 10 OV-PDOs treated with cisplatin, carboplatin, paclitaxel, gemcitabine, epirubicin, doxorubicin, topotecan, and olaparib. Dots represent five-repetition means. Error bars represent five-repetition standard error of the mean. The statistical analysis of drug response at 0.1 µM was calculated using the chi-square test